Cerebrolysin as an Early Add-on to Reperfusion Therapy: Risk of Hemorrhagic Transformation after Ischemic Stroke (CEREHETIS), a prospective, randomized, multicenter pilot study.

BMC Neurol · 2023 · PMC10041692 · PMID 36973684

Europe PMC DOI

hedged sentences

0.0780

closest p · 1.6× alpha

0.0780

boldest claim

The sentences

a favorable trendp = 0.078so close (0.05 < p ≤ 0.1)

In the ITT population, Cerebrolysin set a favorable trend to lower any HT with a rate of 15.9% versus 23.3% in the control group and a corresponding OR of 0.543 (95% CI: 0.281–1.05; p = 0.078).

also in 313 other papers

a clear trendno p-value reported

have demonstrated a clear trend towards HT rate reduction in patients treated with Cerebrolysin [ 23 ].

also in 5,016 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.